OBJECTIVES The aim of this study was to compare long-term survival between patients with severe coronary artery disease undergoing coronary artery bypass grafting (CABG) and those undergoing percutaneous coronary intervention (PCI) achieving complete revascularization (CR) or incomplete revascularization.
C oronary artery bypass grafting (CABG) offers a better survival rate compared with percutaneous coronary intervention (PCI) in patients with severe coronary artery disease (1), multivessel disease (2, 3) , and diabetes (4) . Therefore, CABG has been considered the standard revascularization strategy in the treatment of severe coronary artery disease (5, 6) . However, previous studies were limited by the high prevalence of incomplete revascularization (IR). Although randomized trials intended to enroll patients with anatomy amenable to both CABG and PCI by protocol, a significant proportion of patients did not achieve complete revascularization (CR), particularly in patients undergoing PCI. IR has been known to have a negative impact on outcomes (7) (8) (9) . In addition, a recent study demonstrated that inferior outcomes of PCI compared with CABG were observed only in patients with IR, whereas patients achieving CR showed similar outcomes between PCI and CABG, suggesting the importance of the completeness of revascularization in decision making regarding revascularization strategy in patients with multivessel coronary artery diseases (10) .
In the present study, we hypothesized that when severe coronary artery disease was completely revascularized by either revascularization strategy, PCI and CABG would show similar long-term survival. Based on a patient-level pooled database from 3 randomized trials enrolling patients with left main and multivessel disease, we compared CABG versus PCI with drug-eluting stent implantation according to the completeness of revascularization with respect to long-term survival.
METHODS
STUDY PATIENTS. The study designs, detailed entry criteria, and outcomes of individual trials have been described previously (11) (12) (13) . In brief, these trials were multicenter and multinational; SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Patients eligible for both CABG and PCI were randomized to treatment with either strategy. PCI was performed using paclitaxel-eluting stents in the SYNTAX trial, sirolimus-eluting stents in the PRECOMBAT trial, and everolimus-eluting stents in the BEST trial.
COMPLETENESS OF REVASCULARIZATION.
Completeness of revascularization was prospectively determined after the revascularization procedure by the operator (14) . CR is defined as the treatment of any lesions with more than 50% diameter stenosis in vessels $1.5 mm in the SYNTAX trial (11), $2.0 mm in the BEST trial (13) , and $2.5 mm in the PRECOMBAT trial (12) , as estimated on the diagnostic angiogram.
DATA COLLECTION. The principal investigators in each trial (S.-J.P., P.W.S.) programmed a protocol with the pre-specified outcomes and a common set of baseline variables. Individual patient data from each trial were sent to the coordinating board of Asan Medical Center in Seoul, Korea, and merged for analysis. The pooled database was checked for completeness and consistency by investigators at the Asan Medical Center. A committee blinded to randomization adjudicated all clinical endpoints of each study.
Unless specified, previously reported definitions from each study were used for variables. In addition, the definition of the CR was followed by the definition of the individual studies as described previously.
STUDY OUTCOMES. The primary outcome was death from any cause. The secondary outcomes were a composite of death, myocardial infarction (MI), or stroke; cardiac death; MI; stroke; and any repeat revascularization. Previously reported definitions from each study were used for individual clinical outcomes (11) (12) (13) . Time-to-event outcomes were displayed using Kaplan-Meier methodology, compared using the log-rank test in the overall cohort. To adjust for any potential confounders, propensity score matching analysis was performed using the logistic regression model. We tested all available variables that could be of potential relevance. Matching was performed with a 1:1 matching protocol using the nearest neighbor matching algorithm, with a caliper width equal to 0.2 of the SD of the propensity score. Stratified Cox proportional hazard models were used to assess the hazard ratio of the IR group compared with the CR group among the matched PCI and CABG populations.
In addition, multivariate Cox proportional hazards models were used to compare the outcomes of the CABG CR group with the CABG IR, PCI CR, and PCI IR groups. The proportional hazards assumption regarding treatment assignment was confirmed using the Schoenfeld residuals test; no relevant violations of the assumption were found. Analyses were carried out by an independent statistician who was unaware Ahn et al. IMA ¼ internal mammary artery; other abbreviations as in Table 1 . MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention. Table 1 ). In the PCI group, CR patients required more stents and longer stents. In the CABG group, CR patients required more grafts ( Table 2) . Tables 1 and 2 ).
In addition, compared with patients undergoing CABG who achieved CR, those undergoing PCI who achieved IR had a higher risk for death from any cause and for cardiac death. However, there was no significant difference between patients undergoing CABG and PCI with CR regarding the risk for death from any cause and for cardiac death. Even after adjustment, consistent findings were observed ( Figure 4 , Table 3 ). Table 3) . Ahn et al. Table 4 ).
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S

DISCUSSION
We found that for the treatment of severe coronary artery disease (left main and multivessel disease), PCI resulting in CR was associated with a similar long-term survival rate to CABG resulting in CR, whereas PCI resulting in IR produced a lower survival rate during the 4.9-year follow-up period. These findings were consistent in subgroups with high SYNTAX scores (>32), diabetes, and multivessel disease. Therefore, the ability to achieve CR should enter into the decision algorithm for choice of revascularization strategy.
Previous studies demonstrated that CR conferred a favorable impact on prognosis among patients undergoing PCI with bare-metal stents (8) and drugeluting stents (9) , in acute coronary syndrome (15) , and in acute MI (16) . In addition, residual coronary stenosis after PCI was a nidus of new events in the future (17) . Although another study showed the irrelevance of CR to long-term prognosis after PCI (18), a recent meta-analysis showed that PCI with CR was associated with a reduction in mortality of 27%, in MI of 31%, and in repeat revascularization of 26% compared with PCI with IR in patients with multivessel disease (19) . In contrast, as shown in our study, the clinical benefit of CR was less prominent in patients undergoing CABG, as long as the left anterior descending coronary artery was successfully grafted, particularly by using the internal mammary artery (18, 20, 21) . Nevertheless, a meta-analysis showed that CR was associated with a reduction in mortality of 24% compared with IR in patients undergoing CABG (19) . Therefore, CR was considered a goal to reach in both PCI and CABG. Abbreviations as in Table 1 .
Surgery Versus Stents With Complete Revascularization undergoing PCI with CR and CABG, whereas patients undergoing PCI with IR had a higher mortality rate.
With respect to the risk for MI and any repeat revascularization, the PCI group showed a higher risk for events than the CABG group, regardless of achieving CR or IR, which is a well-known limitation of PCI and is considered a trade-off for its lesser invasiveness, although the higher risk for MI or any repeat revascularization did not translate into high mortality in PCI with CR.
This study suggests a number of discussion points.
First, despite current clinical recommendations, not all stenoses could be revascularized by either PCI or CABG. In our study, CR was achieved in 62% of the overall population, 57% in the PCI group, and 67% in the CABG group. The rate of CR was lower than in earlier studies (22, 23) but was similar to more recently reported ones from contemporary large registries (8, 9, 18) . The ability to achieve CR was not always a matter of choice, because several anatomic situations made it difficult to achieve CR, including chronic total occlusion and multiple lesions for PCI and diffuse disease or a narrowed (#2 mm) segment distal to the lesion (7). In addition, IR was associated with a greater burden of anatomic coronary complexity and clinical comorbidity. Therefore, the negative impact of IR could be partly understood in this context (14) . Otherwise, CABG would be favored.
Third, subgroup analysis showed that patients with high SYNTAX scores, multivessel disease, and diabetes showed comparable long-term mortality when CR was achieved. Based on results from clinical trials, clinical guidelines favor CABG as the primary revascularization strategy in these groups (1,2,4). Therefore, these findings support the notion that the ability to achieve CR should be considered in the decision tree for preferred revascularization strategy in addition to the established anatomic scoring system or specific clinical entities.
STUDY LIMITATIONS. First, although this was a pooled analysis of randomized trials, the strategy of CR and IR was not randomized. WHAT IS NEW? In this study, patients undergoing PCI achieving CR showed similar long-term survival to those undergoing CABG with CR, whereas PCI with IR produced a lower survival rate. Therefore, the ability to achieve CR should enter into the decision algorithm for choice of revascularization strategy.
WHAT IS NEXT? Future clinical trials comparing CABG versus PCI with CR in patients with multivessel coronary artery disease are needed. Surgery Versus Stents With Complete Revascularization
